Literature DB >> 7515552

Diagnosis and treatment for Bell's palsy associated with diabetes mellitus.

O Saito1, M Aoyagi, H Tojima, Y Koike.   

Abstract

The method of detecting diabetes mellitus and estimating the diabetic control status in patients with Bell's palsy, and the effect of high-dose steroid therapy for Bell's palsy accompanied by diabetes were investigated. From October 1987, hemoglobin A1c (HbA1c) was introduced to detect diabetes in 288 out of 372 patients with Bell's palsy, as a screening test for DM. Thirty-six diabetics with complete facial palsy were treated by high dose steroid therapy as described by Stennert. Hemoglobin A1c was useful in diagnosing diabetes and in assessing the diabetic control. Many patients under diabetic therapy kept their diabetes under good control. In cases of complete palsy, high-dose steroid therapy, at a cure rate of 97.4%, was highly effective in treating diabetes-accompanied Bell's palsy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515552     DOI: 10.3109/00016489409128322

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  4 in total

1.  The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy).

Authors:  Josef Georg Heckmann; Peter Paul Urban; Susanne Pitz; Orlando Guntinas-Lichius; Ildikό Gágyor
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

2.  Intratympanic Steroid Treatment of Bell's Palsy in Patients with Comorbid Disease: A Preliminary Report.

Authors:  Deniz Demir; Sena Genç; Mehmet Güven; Mahmut Sinan Yılmaz; Ahmet Kara; Ünal Erkorkmaz
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

3.  Susceptibility of isolated rat facial nerve to anaerobic stress.

Authors:  R Jund; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 4.  Management of Bell's palsy.

Authors:  Dhruvashree Somasundara; Frank Sullivan
Journal:  Aust Prescr       Date:  2017-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.